Trial Profile
A clinical trial of nivolumab in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (NCCH1510,OSCAR trial)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2021
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary)
- Indications Alveolar soft part sarcoma; Clear cell sarcoma
- Focus Therapeutic Use
- Acronyms OSCAR
- 26 Apr 2021 Status changed from active, no longer recruiting to completed.
- 26 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 21 Nov 2016 Status changed from not yet recruiting to recruiting.